Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effect of UDCA on Statin-Induced Diabetes and Glucose Intolerance
NCT05500937Phase 3Unknown
- Sponsor
- First Affiliated Hospital of Xi'an Jiaotong University
- Start
- Mar 2021
- Primary completion
- Dec 2023
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 3 trial of ursodeoxycholic acid in diabetes mellitus (DM), glucose intolerance, sponsored by First Affiliated Hospital of Xi'an Jiaotong University. Status: unknown.
02
Drugs
ursodeoxycholic acid
03
Conditions
diabetes mellitus (DM)glucose intolerance
Beyond the preview
Go deeper on NCT05500937.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05500937.